SCHEMBL21687753

SCHEMBL21687753

N#Cc1ccc([Si](c2ccccc2)(c2ccccc2)c2ccccc2)c(-c2cccc(-n3c4ccccc4c4ccccc43)c2)c1C#N

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.38
ALDH1A1 P00352 3/20 0.38
LMNA P02545 2/20 0.38
HPGD P15428 2/20 0.38
MAPK1 P28482 1/20 0.38
HIF1A Q16665 1/20 0.37
KDM4E B2RXH2 3/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
TSHR P16473 2/20 0.34
KMT2A Q03164 3/20 0.32
MEN1 O00255 2/20 0.32
GLA P06280 1/20 0.32
GAA P10253 1/20 0.32
CRHBP P24387 1/20 0.32
CRHR2 Q13324 1/20 0.32
ADORA1 P30542 1/20 0.32
HTR3A P46098 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
CYP11B2 P19099 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21687537 0.94 ALDH1A1 (0.34) SMN1; SMN2ALDH1A1LMNAHPGDMAPK1
SCHEMBL21687755 0.91 SMN1; SMN2 (0.38) SMN1; SMN2ALDH1A1LMNAHPGDMAPK1
SCHEMBL21687973 0.88 KDM4E (0.39) SMN1; SMN2ALDH1A1LMNAHPGDMAPK1
SCHEMBL21687849 0.88 KDM4E (0.39) SMN1; SMN2ALDH1A1LMNAHPGDMAPK1
SCHEMBL21687510 0.86 LMNA (0.34) SMN1; SMN2ALDH1A1LMNAHPGDMAPK1
SCHEMBL21687602 0.84 ALDH1A1 (0.40) SMN1; SMN2ALDH1A1LMNAHPGDMAPK1
SCHEMBL21687446 0.84 KDM4E (0.40) SMN1; SMN2ALDH1A1LMNAHPGDMAPK1
SCHEMBL21688107 0.83 KDM4E (0.37) SMN1; SMN2ALDH1A1LMNAHPGDMAPK1
SCHEMBL21687727 0.83 ALDH1A1 (0.40) SMN1; SMN2ALDH1A1LMNAHPGDMAPK1
SCHEMBL21687541 0.83 KDM4E (0.41) SMN1; SMN2ALDH1A1LMNAHPGDMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-12-14 US disclosed
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-02-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200044168-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING CONDENSED CYCLIC COMPOUND CRY1, CCNL2, CCNE2 SMN1; SMN2 4039/4885ALDH1A1 616/4885LMNA 1582/4885
US-11201300-B2 Condensed cyclic compound and organic light-emitting device including condensed cyclic compound CRY1, CCNL2, CCNE2 SMN1; SMN2 4039/4885ALDH1A1 616/4885LMNA 1582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.